SCHEMBL2855286

SCHEMBL2855286

CCOC(=O)Oc1sc2nc(-c3ccccc3)cc(C)c2c1NC(=S)NC(=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
PKM P14618 1/20 0.47
KCNH2 Q12809 1/20 0.47
ALDH1A1 P00352 6/20 0.44
LMNA P02545 4/20 0.44
MAPT P10636 6/20 0.44
ALOX12 P18054 2/20 0.44
POLB P06746 1/20 0.44
CYP1A2 P05177 2/20 0.43
CYP3A4 P08684 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
NPC1 O15118 5/20 0.42
RAB9A P51151 5/20 0.42
RXFP1 Q9HBX9 1/20 0.40
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1322018 0.86 MEN1 (0.58) MEN1KMT2ASMN1; SMN2PKMKCNH2
SCHEMBL2853637 0.78 MEN1 (0.61) MEN1KMT2ASMN1; SMN2ALDH1A1MAPT
SCHEMBL5729872 0.66 MEN1 (0.67) MEN1KMT2ASMN1; SMN2ALDH1A1MAPT
SCHEMBL1322128 0.65 MEN1 (0.73) MEN1KMT2ASMN1; SMN2ALDH1A1LMNA
SCHEMBL8616512 0.64 ALDH1A1 (0.67) SMN1; SMN2ALDH1A1LMNAMAPTALOX12
SCHEMBL5443717 0.64 ALDH1A1 (0.84) SMN1; SMN2ALDH1A1LMNAMAPTALOX12
SCHEMBL11258013 0.64 EPHX1 (0.72) SMN1; SMN2ALDH1A1LMNAMAPTALOX12
SCHEMBL11237910 0.63 EPHX1 (0.56) MEN1KMT2ASMN1; SMN2PKMKCNH2
SCHEMBL9311503 0.63 EPHX1 (0.62) MEN1KMT2ASMN1; SMN2ALDH1A1LMNA
SCHEMBL16030042 0.63 ALDH1A1 (0.62) SMN1; SMN2ALDH1A1LMNAMAPTALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1773840-B1 SUBSTITUTED PYRIDO[3',2':4,5]THIENO[3,2-D]PYRIMIDINES AND PYRIDO[3',2':4,5]FURO[3,2-D]-PYRIMIDINES FOR USE AS INHIBITORS OF PDA-4 AND/OR TNF-ALPHA RELEASE MEDICINES CO LEIPZIG GMBH (DE) 2010-01-20 EP disclosed
EP-1773840-A1 SUBSTITUTED PYRIDO[3',2':4,5]THIENO[3,2-D]PYRIMIDINES AND PYRIDO[3',2':4,5]FURO[3,2-D]-PYRIMIDINES FOR USE AS INHIBITORS OF PDA-4 AND/OR TNF-ALPHA RELEASE Curacyte Discovery GmbH (DE) 2007-04-18 EP disclosed
WO-2006010568-A2 SUBSTITUTED PYRIDO[3',2':4,5]THIENO[3,2-D]PYRIMIDINE-2,4(1 H,3H)-DIONES AND -4(3H)-ONES, PYRIDO[3',2':4,5]FURO[3,2-D]PYRIMIDINE-2,4(1 H,3H)-DIONES AND -4(3H)-ONES, AND USE THEREOF AS INHIBITORS OF TNF-ALPHA RELEASE CURACYTE DISCOVERY GMBH (DE) 2006-02-02 WO disclosed
WO-2006010567-A1 SUBSTITUTED PYRIDO[3', 2': 4, 5]THIENO[3,2-D]PYRIMIDINES AND PYRIDO[3', 2': 4, 5]FURO[3, 2, D]PYRIMIDINES USED AS INHIBITORS OF THE PDE-4 AND/OR THE RELEASE OF TNF$G(A) CURACYTE DISCOVERY GMBH (DE) 2006-02-02 WO disclosed
EP-1619197-A1 Substituted Pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-2,4(1H,3H)diones and -4(3H)ones as well as Pyrido[3',2':4,5]furo[3,2-d]-pyrimidin-2,4(1H,3H)diones und -4(3H)ones as inhibitors of TNF-alpha release Curacyte Discovery GmbH (DE) 2006-01-25 EP disclosed
EP-1619196-A1 Substituted Pyrido[3',2':4,5]thieno[3,2-d]pyrimidines and Pyrido[3',2':4,5]furo[3,2-d]-pyrimidines for use as inhibitors of PDA-4 and/or TNF-alpha release Curacyte Discovery GmbH (DE) 2006-01-25 EP disclosed